Item 2.02 Results of Operations and Financial Condition.

On August 9, 2021, Heron Therapeutics, Inc. ("Company") issued a press release announcing its financial results for the three and six months ended June 30, 2021 ("Earnings Press Release"). A copy of the Earnings Press Release is furnished as Exhibit 99.1.

This Item 2.02 and the Earnings Press Release attached hereto as Exhibit 99.1, insofar as they disclose information regarding the Company's results of operations or financial condition for the three and six months ended June 30, 2021, are being furnished to the Securities and Exchange Commission.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.



Exhibit No.   Description

99.1            Earnings Press Release, dated August 9, 2021
104           Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses